Pangenomic expands Nara.Care with DNA program launch

Ms. Maryam Marissen reports PANGENOMIC HEALTH EXPANDS NARACARE.AI PLATFORM WITH LAUNCH OF DNA TESTING PROGRAM Pangenomic Health Inc. has launched a DNA testing program as part of its Nara.Care artificial intelligence platform for personalized wellness. Working with a leading developer of DNA testing technologies, the company will market its Agenta branded DNA testing kits to health-conscious consumers in Canada as part of an initial rollout campaign. The company plans to expand marketing into the United States in early 2026. "We believe consumers are looking for better information about their unique health situation to help guide their personal wellness plans," said Maryam Marissen, president and chief executive officer of Pangenomic Health. "The foundation of our NaraCare.AI platform is personalization, and there is no better baseline for that foundation than incorporating the unique genetic makeup of each individual." The Agenta DNA tests will deliver significant data into the Nara.Care AI platform that uses leading artificial intelligence models to provide actionable insights into diet, fitness, metabolism, brain function, and overall health and wellness. Given the sensitivity of genomic data, the company will implement appropriate safeguards to protect the privacy of all health data. The Agenta DNA testing kits will be available for purchase this quarter on the Agenta Health e-commerce site. About Pangenomic Health Inc. Pangenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Registered as a British Columbia benefit company, Pangenomic Health's mission is to promote alternative health solutions tailored to the health profile of each individual. We seek Safe Harbor.